SMAD2 and ovarian carcinoma: In the present study, we confirmed that the blockade of UCHL5 activity by the DUB inhibitor bAP15 inhibited expression of phospho-Smad2/Smad3 in a concentration-dependent manner and induced apoptosis in ovarian cancer cells.